(Q33975829)

English

Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Lynn C. Hartmann

3

object named as

Hartmann LC

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Hauge MD

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Long HJ

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Edmonson JH

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Webb MJ

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Su J

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 November 1992

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

299-301

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1487403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parenteral formulation of hexamethylmelamine potentially suitable for use in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/1487403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hexamethylmelamine: a critical review of an active drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/1487403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1487403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hexamethylmelamine as a single second-line agent in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1487403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of hexamethylmelamine as salvage therapy in ovarian epithelial adenocarcinoma resistant to combination chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1487403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00944184

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33975829&oldid=2196078021"